Global Porcine Circovirus Diseases Vaccine Market Growth 2026-2032
The global Porcine Circovirus Diseases Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Porcine Circovirus Diseases Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Porcine Circovirus Diseases Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Porcine Circovirus Diseases Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Porcine Circovirus Diseases Vaccine players cover Boehringer Ingelheim, Zoetis, Hile Bio-Technology, Pulike Biological Engineering, Jinyu Bio-technology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Porcine Circovirus Diseases Vaccine Industry Forecast? looks at past sales and reviews total world Porcine Circovirus Diseases Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Porcine Circovirus Diseases Vaccine sales for 2026 through 2032. With Porcine Circovirus Diseases Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Porcine Circovirus Diseases Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Porcine Circovirus Diseases Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Porcine Circovirus Diseases Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Porcine Circovirus Diseases Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Porcine Circovirus Diseases Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Porcine Circovirus Diseases Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Porcine Circovirus Diseases Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for Porcine Circovirus Diseases Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Porcine Circovirus Diseases Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Porcine Circovirus Diseases Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Porcine Circovirus Diseases Vaccine players cover Boehringer Ingelheim, Zoetis, Hile Bio-Technology, Pulike Biological Engineering, Jinyu Bio-technology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Porcine Circovirus Diseases Vaccine Industry Forecast? looks at past sales and reviews total world Porcine Circovirus Diseases Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Porcine Circovirus Diseases Vaccine sales for 2026 through 2032. With Porcine Circovirus Diseases Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Porcine Circovirus Diseases Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Porcine Circovirus Diseases Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Porcine Circovirus Diseases Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Porcine Circovirus Diseases Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Porcine Circovirus Diseases Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Porcine Circovirus Diseases Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Porcine Circovirus Diseases Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Inactivated Vaccine
- Genetically Engineered Vaccine
- Piglet
- Fertile Sow
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Boehringer Ingelheim
- Zoetis
- Hile Bio-Technology
- Pulike Biological Engineering
- Jinyu Bio-technology
- Merck
- Ceva
- Yebio Bioengineering
- Jinhe Biotechnology
- Nannong Hi-Tech
- What is the 10-year outlook for the global Porcine Circovirus Diseases Vaccine market?
- What factors are driving Porcine Circovirus Diseases Vaccine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Porcine Circovirus Diseases Vaccine market opportunities vary by end market size?
- How does Porcine Circovirus Diseases Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Porcine Circovirus Diseases Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Porcine Circovirus Diseases Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Porcine Circovirus Diseases Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Porcine Circovirus Diseases Vaccine Segment by Type
2.2.1 Inactivated Vaccine
2.2.2 Genetically Engineered Vaccine
2.2.3 Porcine Circovirus Diseases Vaccine Sales by Type
2.2.3.1 Global Porcine Circovirus Diseases Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Porcine Circovirus Diseases Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Porcine Circovirus Diseases Vaccine Sale Price by Type (2021-2026)
2.3 Porcine Circovirus Diseases Vaccine Segment by Application
2.3.1 Piglet
2.3.2 Fertile Sow
2.3.3 Porcine Circovirus Diseases Vaccine Sales by Application
2.3.3.1 Global Porcine Circovirus Diseases Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Porcine Circovirus Diseases Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Porcine Circovirus Diseases Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Porcine Circovirus Diseases Vaccine Breakdown Data by Company
3.1.1 Global Porcine Circovirus Diseases Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Porcine Circovirus Diseases Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Porcine Circovirus Diseases Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Porcine Circovirus Diseases Vaccine Revenue by Company (2021-2026)
3.2.2 Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Porcine Circovirus Diseases Vaccine Sale Price by Company
3.4 Key Manufacturers Porcine Circovirus Diseases Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Porcine Circovirus Diseases Vaccine Product Location Distribution
3.4.2 Players Porcine Circovirus Diseases Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PORCINE CIRCOVIRUS DISEASES VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Porcine Circovirus Diseases Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Porcine Circovirus Diseases Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Porcine Circovirus Diseases Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Porcine Circovirus Diseases Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Porcine Circovirus Diseases Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Porcine Circovirus Diseases Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Porcine Circovirus Diseases Vaccine Sales Growth
4.4 APAC Porcine Circovirus Diseases Vaccine Sales Growth
4.5 Europe Porcine Circovirus Diseases Vaccine Sales Growth
4.6 Middle East & Africa Porcine Circovirus Diseases Vaccine Sales Growth
5 AMERICAS
5.1 Americas Porcine Circovirus Diseases Vaccine Sales by Country
5.1.1 Americas Porcine Circovirus Diseases Vaccine Sales by Country (2021-2026)
5.1.2 Americas Porcine Circovirus Diseases Vaccine Revenue by Country (2021-2026)
5.2 Americas Porcine Circovirus Diseases Vaccine Sales by Type (2021-2026)
5.3 Americas Porcine Circovirus Diseases Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Porcine Circovirus Diseases Vaccine Sales by Region
6.1.1 APAC Porcine Circovirus Diseases Vaccine Sales by Region (2021-2026)
6.1.2 APAC Porcine Circovirus Diseases Vaccine Revenue by Region (2021-2026)
6.2 APAC Porcine Circovirus Diseases Vaccine Sales by Type (2021-2026)
6.3 APAC Porcine Circovirus Diseases Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Porcine Circovirus Diseases Vaccine by Country
7.1.1 Europe Porcine Circovirus Diseases Vaccine Sales by Country (2021-2026)
7.1.2 Europe Porcine Circovirus Diseases Vaccine Revenue by Country (2021-2026)
7.2 Europe Porcine Circovirus Diseases Vaccine Sales by Type (2021-2026)
7.3 Europe Porcine Circovirus Diseases Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Porcine Circovirus Diseases Vaccine by Country
8.1.1 Middle East & Africa Porcine Circovirus Diseases Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Porcine Circovirus Diseases Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Porcine Circovirus Diseases Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Porcine Circovirus Diseases Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Porcine Circovirus Diseases Vaccine
10.3 Manufacturing Process Analysis of Porcine Circovirus Diseases Vaccine
10.4 Industry Chain Structure of Porcine Circovirus Diseases Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Porcine Circovirus Diseases Vaccine Distributors
11.3 Porcine Circovirus Diseases Vaccine Customer
12 WORLD FORECAST REVIEW FOR PORCINE CIRCOVIRUS DISEASES VACCINE BY GEOGRAPHIC REGION
12.1 Global Porcine Circovirus Diseases Vaccine Market Size Forecast by Region
12.1.1 Global Porcine Circovirus Diseases Vaccine Forecast by Region (2027-2032)
12.1.2 Global Porcine Circovirus Diseases Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Porcine Circovirus Diseases Vaccine Forecast by Type (2027-2032)
12.7 Global Porcine Circovirus Diseases Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Porcine Circovirus Diseases Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 Zoetis
13.2.1 Zoetis Company Information
13.2.2 Zoetis Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
13.2.3 Zoetis Porcine Circovirus Diseases Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Zoetis Main Business Overview
13.2.5 Zoetis Latest Developments
13.3 Hile Bio-Technology
13.3.1 Hile Bio-Technology Company Information
13.3.2 Hile Bio-Technology Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
13.3.3 Hile Bio-Technology Porcine Circovirus Diseases Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Hile Bio-Technology Main Business Overview
13.3.5 Hile Bio-Technology Latest Developments
13.4 Pulike Biological Engineering
13.4.1 Pulike Biological Engineering Company Information
13.4.2 Pulike Biological Engineering Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
13.4.3 Pulike Biological Engineering Porcine Circovirus Diseases Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Pulike Biological Engineering Main Business Overview
13.4.5 Pulike Biological Engineering Latest Developments
13.5 Jinyu Bio-technology
13.5.1 Jinyu Bio-technology Company Information
13.5.2 Jinyu Bio-technology Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
13.5.3 Jinyu Bio-technology Porcine Circovirus Diseases Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Jinyu Bio-technology Main Business Overview
13.5.5 Jinyu Bio-technology Latest Developments
13.6 Merck
13.6.1 Merck Company Information
13.6.2 Merck Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
13.6.3 Merck Porcine Circovirus Diseases Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Merck Main Business Overview
13.6.5 Merck Latest Developments
13.7 Ceva
13.7.1 Ceva Company Information
13.7.2 Ceva Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
13.7.3 Ceva Porcine Circovirus Diseases Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Ceva Main Business Overview
13.7.5 Ceva Latest Developments
13.8 Yebio Bioengineering
13.8.1 Yebio Bioengineering Company Information
13.8.2 Yebio Bioengineering Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
13.8.3 Yebio Bioengineering Porcine Circovirus Diseases Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Yebio Bioengineering Main Business Overview
13.8.5 Yebio Bioengineering Latest Developments
13.9 Jinhe Biotechnology
13.9.1 Jinhe Biotechnology Company Information
13.9.2 Jinhe Biotechnology Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
13.9.3 Jinhe Biotechnology Porcine Circovirus Diseases Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Jinhe Biotechnology Main Business Overview
13.9.5 Jinhe Biotechnology Latest Developments
13.10 Nannong Hi-Tech
13.10.1 Nannong Hi-Tech Company Information
13.10.2 Nannong Hi-Tech Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
13.10.3 Nannong Hi-Tech Porcine Circovirus Diseases Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Nannong Hi-Tech Main Business Overview
13.10.5 Nannong Hi-Tech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Porcine Circovirus Diseases Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Porcine Circovirus Diseases Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Porcine Circovirus Diseases Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Porcine Circovirus Diseases Vaccine Segment by Type
2.2.1 Inactivated Vaccine
2.2.2 Genetically Engineered Vaccine
2.2.3 Porcine Circovirus Diseases Vaccine Sales by Type
2.2.3.1 Global Porcine Circovirus Diseases Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Porcine Circovirus Diseases Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Porcine Circovirus Diseases Vaccine Sale Price by Type (2021-2026)
2.3 Porcine Circovirus Diseases Vaccine Segment by Application
2.3.1 Piglet
2.3.2 Fertile Sow
2.3.3 Porcine Circovirus Diseases Vaccine Sales by Application
2.3.3.1 Global Porcine Circovirus Diseases Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Porcine Circovirus Diseases Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Porcine Circovirus Diseases Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Porcine Circovirus Diseases Vaccine Breakdown Data by Company
3.1.1 Global Porcine Circovirus Diseases Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Porcine Circovirus Diseases Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Porcine Circovirus Diseases Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Porcine Circovirus Diseases Vaccine Revenue by Company (2021-2026)
3.2.2 Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Porcine Circovirus Diseases Vaccine Sale Price by Company
3.4 Key Manufacturers Porcine Circovirus Diseases Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Porcine Circovirus Diseases Vaccine Product Location Distribution
3.4.2 Players Porcine Circovirus Diseases Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PORCINE CIRCOVIRUS DISEASES VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Porcine Circovirus Diseases Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Porcine Circovirus Diseases Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Porcine Circovirus Diseases Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Porcine Circovirus Diseases Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Porcine Circovirus Diseases Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Porcine Circovirus Diseases Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Porcine Circovirus Diseases Vaccine Sales Growth
4.4 APAC Porcine Circovirus Diseases Vaccine Sales Growth
4.5 Europe Porcine Circovirus Diseases Vaccine Sales Growth
4.6 Middle East & Africa Porcine Circovirus Diseases Vaccine Sales Growth
5 AMERICAS
5.1 Americas Porcine Circovirus Diseases Vaccine Sales by Country
5.1.1 Americas Porcine Circovirus Diseases Vaccine Sales by Country (2021-2026)
5.1.2 Americas Porcine Circovirus Diseases Vaccine Revenue by Country (2021-2026)
5.2 Americas Porcine Circovirus Diseases Vaccine Sales by Type (2021-2026)
5.3 Americas Porcine Circovirus Diseases Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Porcine Circovirus Diseases Vaccine Sales by Region
6.1.1 APAC Porcine Circovirus Diseases Vaccine Sales by Region (2021-2026)
6.1.2 APAC Porcine Circovirus Diseases Vaccine Revenue by Region (2021-2026)
6.2 APAC Porcine Circovirus Diseases Vaccine Sales by Type (2021-2026)
6.3 APAC Porcine Circovirus Diseases Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Porcine Circovirus Diseases Vaccine by Country
7.1.1 Europe Porcine Circovirus Diseases Vaccine Sales by Country (2021-2026)
7.1.2 Europe Porcine Circovirus Diseases Vaccine Revenue by Country (2021-2026)
7.2 Europe Porcine Circovirus Diseases Vaccine Sales by Type (2021-2026)
7.3 Europe Porcine Circovirus Diseases Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Porcine Circovirus Diseases Vaccine by Country
8.1.1 Middle East & Africa Porcine Circovirus Diseases Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Porcine Circovirus Diseases Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Porcine Circovirus Diseases Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Porcine Circovirus Diseases Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Porcine Circovirus Diseases Vaccine
10.3 Manufacturing Process Analysis of Porcine Circovirus Diseases Vaccine
10.4 Industry Chain Structure of Porcine Circovirus Diseases Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Porcine Circovirus Diseases Vaccine Distributors
11.3 Porcine Circovirus Diseases Vaccine Customer
12 WORLD FORECAST REVIEW FOR PORCINE CIRCOVIRUS DISEASES VACCINE BY GEOGRAPHIC REGION
12.1 Global Porcine Circovirus Diseases Vaccine Market Size Forecast by Region
12.1.1 Global Porcine Circovirus Diseases Vaccine Forecast by Region (2027-2032)
12.1.2 Global Porcine Circovirus Diseases Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Porcine Circovirus Diseases Vaccine Forecast by Type (2027-2032)
12.7 Global Porcine Circovirus Diseases Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Porcine Circovirus Diseases Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 Zoetis
13.2.1 Zoetis Company Information
13.2.2 Zoetis Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
13.2.3 Zoetis Porcine Circovirus Diseases Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Zoetis Main Business Overview
13.2.5 Zoetis Latest Developments
13.3 Hile Bio-Technology
13.3.1 Hile Bio-Technology Company Information
13.3.2 Hile Bio-Technology Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
13.3.3 Hile Bio-Technology Porcine Circovirus Diseases Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Hile Bio-Technology Main Business Overview
13.3.5 Hile Bio-Technology Latest Developments
13.4 Pulike Biological Engineering
13.4.1 Pulike Biological Engineering Company Information
13.4.2 Pulike Biological Engineering Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
13.4.3 Pulike Biological Engineering Porcine Circovirus Diseases Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Pulike Biological Engineering Main Business Overview
13.4.5 Pulike Biological Engineering Latest Developments
13.5 Jinyu Bio-technology
13.5.1 Jinyu Bio-technology Company Information
13.5.2 Jinyu Bio-technology Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
13.5.3 Jinyu Bio-technology Porcine Circovirus Diseases Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Jinyu Bio-technology Main Business Overview
13.5.5 Jinyu Bio-technology Latest Developments
13.6 Merck
13.6.1 Merck Company Information
13.6.2 Merck Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
13.6.3 Merck Porcine Circovirus Diseases Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Merck Main Business Overview
13.6.5 Merck Latest Developments
13.7 Ceva
13.7.1 Ceva Company Information
13.7.2 Ceva Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
13.7.3 Ceva Porcine Circovirus Diseases Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Ceva Main Business Overview
13.7.5 Ceva Latest Developments
13.8 Yebio Bioengineering
13.8.1 Yebio Bioengineering Company Information
13.8.2 Yebio Bioengineering Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
13.8.3 Yebio Bioengineering Porcine Circovirus Diseases Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Yebio Bioengineering Main Business Overview
13.8.5 Yebio Bioengineering Latest Developments
13.9 Jinhe Biotechnology
13.9.1 Jinhe Biotechnology Company Information
13.9.2 Jinhe Biotechnology Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
13.9.3 Jinhe Biotechnology Porcine Circovirus Diseases Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Jinhe Biotechnology Main Business Overview
13.9.5 Jinhe Biotechnology Latest Developments
13.10 Nannong Hi-Tech
13.10.1 Nannong Hi-Tech Company Information
13.10.2 Nannong Hi-Tech Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
13.10.3 Nannong Hi-Tech Porcine Circovirus Diseases Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Nannong Hi-Tech Main Business Overview
13.10.5 Nannong Hi-Tech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Porcine Circovirus Diseases Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Porcine Circovirus Diseases Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Inactivated Vaccine
Table 4. Major Players of Genetically Engineered Vaccine
Table 5. Global Porcine Circovirus Diseases Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global Porcine Circovirus Diseases Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Porcine Circovirus Diseases Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Porcine Circovirus Diseases Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Porcine Circovirus Diseases Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global Porcine Circovirus Diseases Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Porcine Circovirus Diseases Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Porcine Circovirus Diseases Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Porcine Circovirus Diseases Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global Porcine Circovirus Diseases Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Porcine Circovirus Diseases Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Porcine Circovirus Diseases Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Porcine Circovirus Diseases Vaccine Producing Area Distribution and Sales Area
Table 21. Players Porcine Circovirus Diseases Vaccine Products Offered
Table 22. Porcine Circovirus Diseases Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Porcine Circovirus Diseases Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Porcine Circovirus Diseases Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Porcine Circovirus Diseases Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Porcine Circovirus Diseases Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Porcine Circovirus Diseases Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Porcine Circovirus Diseases Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Porcine Circovirus Diseases Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Porcine Circovirus Diseases Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Porcine Circovirus Diseases Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Porcine Circovirus Diseases Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Porcine Circovirus Diseases Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Porcine Circovirus Diseases Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Porcine Circovirus Diseases Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Porcine Circovirus Diseases Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Porcine Circovirus Diseases Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Porcine Circovirus Diseases Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Porcine Circovirus Diseases Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Porcine Circovirus Diseases Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Porcine Circovirus Diseases Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Porcine Circovirus Diseases Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Porcine Circovirus Diseases Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Porcine Circovirus Diseases Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Porcine Circovirus Diseases Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Porcine Circovirus Diseases Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Porcine Circovirus Diseases Vaccine
Table 52. Key Market Challenges & Risks of Porcine Circovirus Diseases Vaccine
Table 53. Key Industry Trends of Porcine Circovirus Diseases Vaccine
Table 54. Porcine Circovirus Diseases Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Porcine Circovirus Diseases Vaccine Distributors List
Table 57. Porcine Circovirus Diseases Vaccine Customer List
Table 58. Global Porcine Circovirus Diseases Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Porcine Circovirus Diseases Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Porcine Circovirus Diseases Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Porcine Circovirus Diseases Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Porcine Circovirus Diseases Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Porcine Circovirus Diseases Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Porcine Circovirus Diseases Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Porcine Circovirus Diseases Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Porcine Circovirus Diseases Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Porcine Circovirus Diseases Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Porcine Circovirus Diseases Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Porcine Circovirus Diseases Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Porcine Circovirus Diseases Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Porcine Circovirus Diseases Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Boehringer Ingelheim Basic Information, Porcine Circovirus Diseases Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Boehringer Ingelheim Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
Table 74. Boehringer Ingelheim Porcine Circovirus Diseases Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Boehringer Ingelheim Main Business
Table 76. Boehringer Ingelheim Latest Developments
Table 77. Zoetis Basic Information, Porcine Circovirus Diseases Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Zoetis Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
Table 79. Zoetis Porcine Circovirus Diseases Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Zoetis Main Business
Table 81. Zoetis Latest Developments
Table 82. Hile Bio-Technology Basic Information, Porcine Circovirus Diseases Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Hile Bio-Technology Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
Table 84. Hile Bio-Technology Porcine Circovirus Diseases Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Hile Bio-Technology Main Business
Table 86. Hile Bio-Technology Latest Developments
Table 87. Pulike Biological Engineering Basic Information, Porcine Circovirus Diseases Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Pulike Biological Engineering Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
Table 89. Pulike Biological Engineering Porcine Circovirus Diseases Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Pulike Biological Engineering Main Business
Table 91. Pulike Biological Engineering Latest Developments
Table 92. Jinyu Bio-technology Basic Information, Porcine Circovirus Diseases Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Jinyu Bio-technology Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
Table 94. Jinyu Bio-technology Porcine Circovirus Diseases Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Jinyu Bio-technology Main Business
Table 96. Jinyu Bio-technology Latest Developments
Table 97. Merck Basic Information, Porcine Circovirus Diseases Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Merck Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
Table 99. Merck Porcine Circovirus Diseases Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Merck Main Business
Table 101. Merck Latest Developments
Table 102. Ceva Basic Information, Porcine Circovirus Diseases Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Ceva Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
Table 104. Ceva Porcine Circovirus Diseases Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Ceva Main Business
Table 106. Ceva Latest Developments
Table 107. Yebio Bioengineering Basic Information, Porcine Circovirus Diseases Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Yebio Bioengineering Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
Table 109. Yebio Bioengineering Porcine Circovirus Diseases Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Yebio Bioengineering Main Business
Table 111. Yebio Bioengineering Latest Developments
Table 112. Jinhe Biotechnology Basic Information, Porcine Circovirus Diseases Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Jinhe Biotechnology Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
Table 114. Jinhe Biotechnology Porcine Circovirus Diseases Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Jinhe Biotechnology Main Business
Table 116. Jinhe Biotechnology Latest Developments
Table 117. Nannong Hi-Tech Basic Information, Porcine Circovirus Diseases Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Nannong Hi-Tech Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
Table 119. Nannong Hi-Tech Porcine Circovirus Diseases Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Nannong Hi-Tech Main Business
Table 121. Nannong Hi-Tech Latest Developments
Table 1. Porcine Circovirus Diseases Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Porcine Circovirus Diseases Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Inactivated Vaccine
Table 4. Major Players of Genetically Engineered Vaccine
Table 5. Global Porcine Circovirus Diseases Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global Porcine Circovirus Diseases Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Porcine Circovirus Diseases Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Porcine Circovirus Diseases Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Porcine Circovirus Diseases Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global Porcine Circovirus Diseases Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Porcine Circovirus Diseases Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Porcine Circovirus Diseases Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Porcine Circovirus Diseases Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global Porcine Circovirus Diseases Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Porcine Circovirus Diseases Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Porcine Circovirus Diseases Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Porcine Circovirus Diseases Vaccine Producing Area Distribution and Sales Area
Table 21. Players Porcine Circovirus Diseases Vaccine Products Offered
Table 22. Porcine Circovirus Diseases Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Porcine Circovirus Diseases Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Porcine Circovirus Diseases Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Porcine Circovirus Diseases Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Porcine Circovirus Diseases Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Porcine Circovirus Diseases Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Porcine Circovirus Diseases Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Porcine Circovirus Diseases Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Porcine Circovirus Diseases Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Porcine Circovirus Diseases Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Porcine Circovirus Diseases Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Porcine Circovirus Diseases Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Porcine Circovirus Diseases Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Porcine Circovirus Diseases Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Porcine Circovirus Diseases Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Porcine Circovirus Diseases Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Porcine Circovirus Diseases Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Porcine Circovirus Diseases Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Porcine Circovirus Diseases Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Porcine Circovirus Diseases Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Porcine Circovirus Diseases Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Porcine Circovirus Diseases Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Porcine Circovirus Diseases Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Porcine Circovirus Diseases Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Porcine Circovirus Diseases Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Porcine Circovirus Diseases Vaccine
Table 52. Key Market Challenges & Risks of Porcine Circovirus Diseases Vaccine
Table 53. Key Industry Trends of Porcine Circovirus Diseases Vaccine
Table 54. Porcine Circovirus Diseases Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Porcine Circovirus Diseases Vaccine Distributors List
Table 57. Porcine Circovirus Diseases Vaccine Customer List
Table 58. Global Porcine Circovirus Diseases Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Porcine Circovirus Diseases Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Porcine Circovirus Diseases Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Porcine Circovirus Diseases Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Porcine Circovirus Diseases Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Porcine Circovirus Diseases Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Porcine Circovirus Diseases Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Porcine Circovirus Diseases Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Porcine Circovirus Diseases Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Porcine Circovirus Diseases Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Porcine Circovirus Diseases Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Porcine Circovirus Diseases Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Porcine Circovirus Diseases Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Porcine Circovirus Diseases Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Boehringer Ingelheim Basic Information, Porcine Circovirus Diseases Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Boehringer Ingelheim Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
Table 74. Boehringer Ingelheim Porcine Circovirus Diseases Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Boehringer Ingelheim Main Business
Table 76. Boehringer Ingelheim Latest Developments
Table 77. Zoetis Basic Information, Porcine Circovirus Diseases Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Zoetis Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
Table 79. Zoetis Porcine Circovirus Diseases Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Zoetis Main Business
Table 81. Zoetis Latest Developments
Table 82. Hile Bio-Technology Basic Information, Porcine Circovirus Diseases Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Hile Bio-Technology Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
Table 84. Hile Bio-Technology Porcine Circovirus Diseases Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Hile Bio-Technology Main Business
Table 86. Hile Bio-Technology Latest Developments
Table 87. Pulike Biological Engineering Basic Information, Porcine Circovirus Diseases Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Pulike Biological Engineering Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
Table 89. Pulike Biological Engineering Porcine Circovirus Diseases Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Pulike Biological Engineering Main Business
Table 91. Pulike Biological Engineering Latest Developments
Table 92. Jinyu Bio-technology Basic Information, Porcine Circovirus Diseases Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Jinyu Bio-technology Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
Table 94. Jinyu Bio-technology Porcine Circovirus Diseases Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Jinyu Bio-technology Main Business
Table 96. Jinyu Bio-technology Latest Developments
Table 97. Merck Basic Information, Porcine Circovirus Diseases Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Merck Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
Table 99. Merck Porcine Circovirus Diseases Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Merck Main Business
Table 101. Merck Latest Developments
Table 102. Ceva Basic Information, Porcine Circovirus Diseases Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Ceva Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
Table 104. Ceva Porcine Circovirus Diseases Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Ceva Main Business
Table 106. Ceva Latest Developments
Table 107. Yebio Bioengineering Basic Information, Porcine Circovirus Diseases Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Yebio Bioengineering Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
Table 109. Yebio Bioengineering Porcine Circovirus Diseases Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Yebio Bioengineering Main Business
Table 111. Yebio Bioengineering Latest Developments
Table 112. Jinhe Biotechnology Basic Information, Porcine Circovirus Diseases Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Jinhe Biotechnology Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
Table 114. Jinhe Biotechnology Porcine Circovirus Diseases Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Jinhe Biotechnology Main Business
Table 116. Jinhe Biotechnology Latest Developments
Table 117. Nannong Hi-Tech Basic Information, Porcine Circovirus Diseases Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Nannong Hi-Tech Porcine Circovirus Diseases Vaccine Product Portfolios and Specifications
Table 119. Nannong Hi-Tech Porcine Circovirus Diseases Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Nannong Hi-Tech Main Business
Table 121. Nannong Hi-Tech Latest Developments
LIST OF FIGURES
Figure 1. Picture of Porcine Circovirus Diseases Vaccine
Figure 2. Porcine Circovirus Diseases Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Porcine Circovirus Diseases Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Porcine Circovirus Diseases Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Porcine Circovirus Diseases Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Porcine Circovirus Diseases Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Porcine Circovirus Diseases Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Inactivated Vaccine
Figure 12. Product Picture of Genetically Engineered Vaccine
Figure 13. Global Porcine Circovirus Diseases Vaccine Sales Market Share by Type in 2026
Figure 14. Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Porcine Circovirus Diseases Vaccine Consumed in Piglet
Figure 16. Global Porcine Circovirus Diseases Vaccine Market: Piglet (2021-2026) & (K Units)
Figure 17. Porcine Circovirus Diseases Vaccine Consumed in Fertile Sow
Figure 18. Global Porcine Circovirus Diseases Vaccine Market: Fertile Sow (2021-2026) & (K Units)
Figure 19. Global Porcine Circovirus Diseases Vaccine Sale Market Share by Application (2025)
Figure 20. Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Application in 2026
Figure 21. Porcine Circovirus Diseases Vaccine Sales by Company in 2026 (K Units)
Figure 22. Global Porcine Circovirus Diseases Vaccine Sales Market Share by Company in 2026
Figure 23. Porcine Circovirus Diseases Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Company in 2026
Figure 25. Global Porcine Circovirus Diseases Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Porcine Circovirus Diseases Vaccine Sales 2021-2026 (K Units)
Figure 28. Americas Porcine Circovirus Diseases Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC Porcine Circovirus Diseases Vaccine Sales 2021-2026 (K Units)
Figure 30. APAC Porcine Circovirus Diseases Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe Porcine Circovirus Diseases Vaccine Sales 2021-2026 (K Units)
Figure 32. Europe Porcine Circovirus Diseases Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Porcine Circovirus Diseases Vaccine Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Porcine Circovirus Diseases Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas Porcine Circovirus Diseases Vaccine Sales Market Share by Country in 2026
Figure 36. Americas Porcine Circovirus Diseases Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas Porcine Circovirus Diseases Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas Porcine Circovirus Diseases Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Porcine Circovirus Diseases Vaccine Sales Market Share by Region in 2026
Figure 44. APAC Porcine Circovirus Diseases Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC Porcine Circovirus Diseases Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC Porcine Circovirus Diseases Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Porcine Circovirus Diseases Vaccine Sales Market Share by Country in 2026
Figure 55. Europe Porcine Circovirus Diseases Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe Porcine Circovirus Diseases Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe Porcine Circovirus Diseases Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Porcine Circovirus Diseases Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Porcine Circovirus Diseases Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Porcine Circovirus Diseases Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Porcine Circovirus Diseases Vaccine in 2026
Figure 72. Manufacturing Process Analysis of Porcine Circovirus Diseases Vaccine
Figure 73. Industry Chain Structure of Porcine Circovirus Diseases Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Porcine Circovirus Diseases Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global Porcine Circovirus Diseases Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Porcine Circovirus Diseases Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Porcine Circovirus Diseases Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Porcine Circovirus Diseases Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Porcine Circovirus Diseases Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Porcine Circovirus Diseases Vaccine
Figure 2. Porcine Circovirus Diseases Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Porcine Circovirus Diseases Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Porcine Circovirus Diseases Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Porcine Circovirus Diseases Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Porcine Circovirus Diseases Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Porcine Circovirus Diseases Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Inactivated Vaccine
Figure 12. Product Picture of Genetically Engineered Vaccine
Figure 13. Global Porcine Circovirus Diseases Vaccine Sales Market Share by Type in 2026
Figure 14. Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Porcine Circovirus Diseases Vaccine Consumed in Piglet
Figure 16. Global Porcine Circovirus Diseases Vaccine Market: Piglet (2021-2026) & (K Units)
Figure 17. Porcine Circovirus Diseases Vaccine Consumed in Fertile Sow
Figure 18. Global Porcine Circovirus Diseases Vaccine Market: Fertile Sow (2021-2026) & (K Units)
Figure 19. Global Porcine Circovirus Diseases Vaccine Sale Market Share by Application (2025)
Figure 20. Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Application in 2026
Figure 21. Porcine Circovirus Diseases Vaccine Sales by Company in 2026 (K Units)
Figure 22. Global Porcine Circovirus Diseases Vaccine Sales Market Share by Company in 2026
Figure 23. Porcine Circovirus Diseases Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Company in 2026
Figure 25. Global Porcine Circovirus Diseases Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Porcine Circovirus Diseases Vaccine Sales 2021-2026 (K Units)
Figure 28. Americas Porcine Circovirus Diseases Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC Porcine Circovirus Diseases Vaccine Sales 2021-2026 (K Units)
Figure 30. APAC Porcine Circovirus Diseases Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe Porcine Circovirus Diseases Vaccine Sales 2021-2026 (K Units)
Figure 32. Europe Porcine Circovirus Diseases Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Porcine Circovirus Diseases Vaccine Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Porcine Circovirus Diseases Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas Porcine Circovirus Diseases Vaccine Sales Market Share by Country in 2026
Figure 36. Americas Porcine Circovirus Diseases Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas Porcine Circovirus Diseases Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas Porcine Circovirus Diseases Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Porcine Circovirus Diseases Vaccine Sales Market Share by Region in 2026
Figure 44. APAC Porcine Circovirus Diseases Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC Porcine Circovirus Diseases Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC Porcine Circovirus Diseases Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Porcine Circovirus Diseases Vaccine Sales Market Share by Country in 2026
Figure 55. Europe Porcine Circovirus Diseases Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe Porcine Circovirus Diseases Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe Porcine Circovirus Diseases Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Porcine Circovirus Diseases Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Porcine Circovirus Diseases Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Porcine Circovirus Diseases Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Porcine Circovirus Diseases Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Porcine Circovirus Diseases Vaccine in 2026
Figure 72. Manufacturing Process Analysis of Porcine Circovirus Diseases Vaccine
Figure 73. Industry Chain Structure of Porcine Circovirus Diseases Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Porcine Circovirus Diseases Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global Porcine Circovirus Diseases Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Porcine Circovirus Diseases Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Porcine Circovirus Diseases Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Porcine Circovirus Diseases Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Porcine Circovirus Diseases Vaccine Revenue Market Share Forecast by Application (2027-2032)
